(SAP) SAP SE - Ratings and Ratios
ERP, HCM, CRM, Spend Management, Business Network
Dividends
| Dividend Yield | 1.13% |
| Yield on Cost 5y | 2.55% |
| Yield CAGR 5y | 8.63% |
| Payout Consistency | 90.0% |
| Payout Ratio | 39.1% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 23.5% |
| Value at Risk 5%th | 37.0% |
| Relative Tail Risk | -4.26% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.46 |
| Alpha | -18.74 |
| CAGR/Max DD | 1.12 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.537 |
| Beta | 0.165 |
| Beta Downside | 0.276 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.26% |
| Mean DD | 5.19% |
| Median DD | 2.69% |
Description: SAP SAP SE December 01, 2025
SAP SE (XETRA:SAP) delivers a comprehensive suite of enterprise software, spanning its flagship SAP S/4HANA ERP platform, SuccessFactors HR suite, and spend-management tools, alongside industry-specific solutions, the Business Technology Platform for app development, and the Business Network for B2B collaboration. Complementary offerings include Signavio for process mining, LeanIX for enterprise-architecture visualization, WalkMe workflow automation, Enable Now e-learning, Taulia working-capital management, and sustainability services, all supported by a global services and support organization.
Key recent metrics highlight SAP’s market position: FY 2023 total revenue reached €27.8 billion, with cloud subscription revenue growing ~18 % year-over-year, reflecting strong demand for SaaS transformation. The company’s growth is driven by macro trends such as accelerating digital-transformation spend, increasing adoption of AI-augmented ERP, and the need for resilient supply-chain networks amid geopolitical uncertainty.
For a deeper, data-driven analysis of SAP’s valuation and risk profile, you may find ValueRay’s research tools useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (7.08b TTM) > 0 and > 6% of Revenue (6% = 2.19b TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 5.78% (prev 5.56%; Δ 0.22pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 7.28b > Net Income 7.08b (YES >=105%, WARN >=100%) |
| Net Debt (666.2m) to EBITDA (11.82b) ratio: 0.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.10 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.18b) change vs 12m ago -0.08% (target <= -2.0% for YES) |
| Gross Margin 73.61% (prev 72.74%; Δ 0.87pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 48.65% (prev 47.77%; Δ 0.89pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 9.00 (EBITDA TTM 11.82b / Interest Expense TTM 1.17b) >= 6 (WARN >= 3) |
Altman Z'' 5.26
| (A) 0.03 = (Total Current Assets 22.22b - Total Current Liabilities 20.11b) / Total Assets 80.37b |
| (B) 0.67 = Retained Earnings (Balance) 53.66b / Total Assets 80.37b |
| (C) 0.14 = EBIT TTM 10.48b / Avg Total Assets 75.01b |
| (D) 1.88 = Book Value of Equity 55.44b / Total Liabilities 29.56b |
| Total Rating: 5.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 82.70
| 1. Piotroski 5.50pt |
| 2. FCF Yield 2.61% |
| 3. FCF Margin 17.68% |
| 4. Debt/Equity 0.21 |
| 5. Debt/Ebitda 0.06 |
| 6. ROIC - WACC (= 9.97)% |
| 7. RoE 15.53% |
| 8. Rev. Trend 82.70% |
| 9. EPS Trend 30.73% |
What is the price of SAP shares?
Over the past week, the price has changed by -2.37%, over one month by -4.67%, over three months by -5.75% and over the past year by -13.01%.
Is SAP a buy, sell or hold?
What are the forecasts/targets for the SAP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 286.8 | 37.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 238.8 | 14.7% |
SAP Fundamental Data Overview December 11, 2025
Market Cap EUR = 244.57b (244.57b EUR * 1.0 EUR.EUR)
P/E Trailing = 34.8259
P/E Forward = 28.7356
P/S = 6.7016
P/B = 5.716
P/EG = 1.0124
Beta = 0.815
Revenue TTM = 36.49b EUR
EBIT TTM = 10.48b EUR
EBITDA TTM = 11.82b EUR
Long Term Debt = 6.09b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.56b EUR (from shortTermDebt, last quarter)
Debt = 10.72b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 666.2m EUR (from netDebt column, last quarter)
Enterprise Value = 246.73b EUR (244.57b + Debt 10.72b - CCE 8.55b)
Interest Coverage Ratio = 9.00 (Ebit TTM 10.48b / Interest Expense TTM 1.17b)
FCF Yield = 2.61% (FCF TTM 6.45b / Enterprise Value 246.73b)
FCF Margin = 17.68% (FCF TTM 6.45b / Revenue TTM 36.49b)
Net Margin = 19.41% (Net Income TTM 7.08b / Revenue TTM 36.49b)
Gross Margin = 73.61% ((Revenue TTM 36.49b - Cost of Revenue TTM 9.63b) / Revenue TTM)
Gross Margin QoQ = 73.50% (prev 73.60%)
Tobins Q-Ratio = 3.07 (Enterprise Value 246.73b / Total Assets 80.37b)
Interest Expense / Debt = 2.91% (Interest Expense 312.0m / Debt 10.72b)
Taxrate = 25.28% (694.0m / 2.75b)
NOPAT = 7.83b (EBIT 10.48b * (1 - 25.28%))
Current Ratio = 1.10 (Total Current Assets 22.22b / Total Current Liabilities 20.11b)
Debt / Equity = 0.21 (Debt 10.72b / totalStockholderEquity, last quarter 50.30b)
Debt / EBITDA = 0.06 (Net Debt 666.2m / EBITDA 11.82b)
Debt / FCF = 0.10 (Net Debt 666.2m / FCF TTM 6.45b)
Total Stockholder Equity = 45.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.81% (Net Income 7.08b / Total Assets 80.37b)
RoE = 15.53% (Net Income TTM 7.08b / Total Stockholder Equity 45.61b)
RoCE = 20.28% (EBIT 10.48b / Capital Employed (Equity 45.61b + L.T.Debt 6.09b))
RoIC = 16.40% (NOPAT 7.83b / Invested Capital 47.75b)
WACC = 6.43% (E(244.57b)/V(255.28b) * Re(6.62%) + D(10.72b)/V(255.28b) * Rd(2.91%) * (1-Tc(0.25)))
Discount Rate = 6.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.04%
[DCF Debug] Terminal Value 79.14% ; FCFE base≈6.73b ; Y1≈7.14b ; Y5≈8.54b
Fair Price DCF = 128.3 (DCF Value 149.43b / Shares Outstanding 1.16b; 5y FCF grow 6.81% → 3.0% )
EPS Correlation: 30.73 | EPS CAGR: -2.07% | SUE: 3.12 | # QB: 1
Revenue Correlation: 82.70 | Revenue CAGR: 3.49% | SUE: -0.10 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.59 | Chg30d=-0.001 | Revisions Net=+1 | Analysts=7
EPS next Year (2026-12-31): EPS=7.16 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+17.4% | Growth Revenue=+11.2%